139 related articles for article (PubMed ID: 16324554)
1. [Dermopathy and peripheral neuropathy].
Roca B
Enferm Infecc Microbiol Clin; 2005 Dec; 23(10):629-30. PubMed ID: 16324554
[No Abstract] [Full Text] [Related]
2. An unusual rash in an elderly man.
Burns J
JAAPA; 2007 Mar; 20(3):43-7. PubMed ID: 17416022
[No Abstract] [Full Text] [Related]
3. Treatment of Hansen's disease.
Alto WA
Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
[No Abstract] [Full Text] [Related]
4. Leprosy in the UK.
Bharucha T; Lockwood D
Br J Hosp Med (Lond); 2016 Oct; 77(10):C154-C156. PubMed ID: 27723400
[No Abstract] [Full Text] [Related]
5. Atypical rash.
Cataño JC; Giraldo DE
Eur J Intern Med; 2019 May; 63():e5-e6. PubMed ID: 30593444
[No Abstract] [Full Text] [Related]
6. Update on leprosy.
Marlowe SN; Lockwood DN
Hosp Med; 2001 Aug; 62(8):471-6. PubMed ID: 11530584
[TBL] [Abstract][Full Text] [Related]
7. Leprosy.
Marcos LA; Conerly S; Walker S
Am J Trop Med Hyg; 2014 Aug; 91(2):216. PubMed ID: 25100789
[No Abstract] [Full Text] [Related]
8. Multidrug therapy regimen for leprosy.
Firooz A
J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
[No Abstract] [Full Text] [Related]
9. Combinations involving dapsone, rifampin, clofazimine, and ethionamide in the treatment of M. leprae infections in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):135-9. PubMed ID: 945234
[No Abstract] [Full Text] [Related]
10. Editorial: Problems and opportunities in the therapy of leprosy.
Jopling WH
Lepr Rev; 1974 Dec; 45(4):285-7. PubMed ID: 4444391
[No Abstract] [Full Text] [Related]
11. Combined therapy in leprosy.
Gatti JC
Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
[No Abstract] [Full Text] [Related]
12. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
Williams DL; Araujo S; Stryjewska BM; Scollard D
Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of leprosy today].
Bahmer FA; Menzel S
Hautarzt; 1987 Jan; 38(1):1-3. PubMed ID: 3557977
[TBL] [Abstract][Full Text] [Related]
14. Polytherapy in multibacillary leprosy patients in Nepal.
Samuel NM; Samual S; Fairbairn T; Adiga RB
Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
[No Abstract] [Full Text] [Related]
15. Recent trends in chemotherapy of leprosy.
Parikh DA; Maniar JK; Parikh AC; Ganapati R
J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
[No Abstract] [Full Text] [Related]
16. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
17. Minocycline is effective and cosmetically preferred to clofazimine by leprosy patients in New York.
Levis WR; Spencer TI; Ladizinski B
J Drugs Dermatol; 2010 Aug; 9(8):906. PubMed ID: 20684139
[No Abstract] [Full Text] [Related]
18. THELEP controlled clinical trials in lepromatous leprosy.
Lepr Rev; 1983 Sep; 54(3):167-76. PubMed ID: 6355720
[No Abstract] [Full Text] [Related]
19. Evolution of the modern chemotherapy of leprosy.
Levy L
Lepr Rev; 1983 Jun; Spec No():69-83. PubMed ID: 6350773
[No Abstract] [Full Text] [Related]
20. Committee 4: workshop on experimental chemotherapy of leprosy.
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2 Suppl):297-303. PubMed ID: 378876
[No Abstract] [Full Text] [Related]
[Next] [New Search]
